Company profile
A new way to treat tremors
Founded in 2017 in Delft, the Netherlands, STIL is revolutionizing tremor treatment with its innovative, non-invasive medical device: the STIL Orthosis. Designed for people suffering from essential tremors, dystonia and Parkinson’s disease, STIL’s device can reduce forearm tremors by more than 80%, restoring people’s independence and enabling activities of daily life.
Clinically proven technology
In 2022, STIL reached a major clinical milestone, when it successfully completed its first clinical trial. This proved effectiveness for essential tremor patients with a forearm tremor. The study got international acknowledgement, when published in the renowned medical journal Movement Disorders. Several other clinical trials are in progress, expanding the medical claims to Parkinson's disease and other movement disorders.
Medical certification and patent protected
STIL holds an ISO 13485 certification, the most important quality management standard in the medical field. Our product is CE-certified and FDA-registered, allowing us to legally sell in all of the EU and US. We have multiple patents protecting the IP of the STIL Orthosis in key countries across the world.
Proven market traction
By 2024, the company had sold hundreds of devices and established key distribution contracts in the Netherlands, Germany, Belgium, and Italy, expanding its reach across Europe. STIL received €3.6 million in funding from reputable investors, including Health Innovations, Rabobank, EIC Accelerator and the Brain Foundation Netherlands.
By investing in STIL, you are supporting a patented, clinically validated technology that addresses a major unmet medical need while offering strong financial growth potential.